Rebound Therapeutics is Surgical Devices in United States that focus on invasive surgery business. Founded in 2015. They cover business area such as developer, medical device, minimally invasive surgery (MIS) procedure, MIS access, therapeutic device, the-art, surgical procedure, neurosurgery, spine, orthopedic surgery, thoracic, general abdominal surgery, physician, MIS procedure, operating room.
2015
( 9 years old in 2024 )
Invasive Surgery
-
13844 Alton Parkway
Suite 120
Irvine, CA 92618
United States
Private
developermedical deviceminimally invasive surgery (MIS) procedureMIS accesstherapeutic devicethe-artsurgical procedureneurosurgeryspineorthopedic surgerythoracicgeneral abdominal surgeryphysicianMIS procedureoperating room
* We use standard office opening hours in near Rebound Therapeutics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Rebound Therapeutics is Surgical Devices business from United States that founded in 2015 (9 years old in 2024), Rebound Therapeutics business is focusing on Invasive Surgery.
Rebound Therapeutics headquarter office and corporate office address is located in 13844 Alton Parkway Suite 120 Irvine, CA 92618 United States.
Rebound Therapeutics was founded in United States.
In 2024, Rebound Therapeutics is currently focus on invasive surgery sector.
Above is snippet of Google Trends for "invasive surgery" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Rebound Therapeutics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
